Dr Rajendra Sharma argues the case for combining traditional healthcare with complementary and alternative medicine to create personal patient treatments…
Functional Medicine is an emerging specialty which considers ‘dysfunction’ of cellular physiology and biochemistry as the cause of chronic conditions and aims to restore function. Patients are more frequently turning towards this form of medicine, as they recognise that much orthodox prescribing is based on placating symptoms with little focus on cure or treatment of underlying cause.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
When any such therapy is offered by conventionally trained doctors, who may also concurrently prescribe orthodox medicine, the term Integrated (or Integrative) Medicine (IM) is now used.
IM medicine is a mixture of conventional with Complementary and Alternative medicine (CAM).
In 2010 a study by Hunt KJ et al showed data from 7630 respondents in the UK.
12.1% of those asked had seen and consulted a practitioner in the preceding 12 months.
29% had been taking prescription drugs and had used CAM alongside in the previous 12 months.
There are many reasons for the popularity of CAM therapies and it is not just the public who seem to be showing an interest. A Californian study in 2015 has shown 75% of 1,770 USA medical students ‘think it would be beneficial for conventional Western medicine to integrate with complementary and alternative medicine (CAM)’.1
As global health systems feel the pressure of increasing costs, the sensibility of combining some Integrated Medicine into national health care seems logical and has been proven as viable. The budget for the NHS in England for 2016/17 is £120 billion. This is forecast to rise by nearly £35 billion in cash terms – an increase of 35% by 2021. Treating people with chronic diseases may account for 86% of our nation’s health care costs based on USA figures.2 Arguably this makes the cost of care, using the current model, economically unsustainable. We need to find ways of changing this slide to affordability.
There are a number of studies suggesting that CAM may reduce medical expenditure and costs3 but others, based on the current paradigm of orthodox medicine, that do not.
In 2008 the UK annual spend on alternative health treatments was £4.5 billion, a market that has grown by nearly 50% in the last decade.4 This increasing expense would be surprising if people were not actually benefiting and may reduce the current increasing expenditure if it keeps patients away from General Practice and hospitals.
Doctors and academics see benefit in better understanding of CAM use by their patients and establishing what is and isn’t working5, yet there continues to be concerted attacks on CAM with authorities not caring to take a balanced view of the evidence and calling it a waste of resources. Unfortunately, lack of finances means a broad defence has yet to be established and studies struggle to be funded.
‘A lack of evidence is not evidence of a lack of efficacy’
Most detractors of IM will argue there is a lack of published evidence to prove the efficacy of CAM and it is generally agreed that too few studies on CAM/IM are initiated and concluded. This is a financial issue as complementary practitioners and centres do not have the necessary funds to publish large studies.
Yet there is an astonishing amount of peer-reviewed, published scientific evidence behind a myriad of naturopathic therapies, but many studies are small and outcomes not repeated frequently due to funding issues. We must not allow a lack of evidence to reflect a lack of efficacy.
It is a sad scenario that despite peer-reviewed and published papers calling for UK curriculum coordinators to improve CAM teaching, there is little movement within medical schools to do so.
Study design is an issue. Much of IM practice is about dealing with an individual rather than his or her disease process. A disease may have many different causes and so one specific treatment may not suit all cases. Double-blind, placebo-controlled research is, therefore, unsuitable for many types of CAM.
But this should not be the only way to evaluate a therapy after all, there are no double-blind, placebo-controlled studies in major surgery. ‘To Cut Is To Cure’ is based on theory then trial and error. Unfortunately, CAM seems not to be allowed that due process despite it being far less dangerous to implement.
Therapy involving an acupuncturist or osteopath treating a similar number of individuals, as might be found on a pharmaceutical trial, may take a variable and considerable length of time depending on the set-up of the trial, the therapy and the variation within the individual patients. It is hard to govern such studies because some patients may respond swiftly whilst others will take much longer. And, of course, placebo is a difficult concept to administer with ‘hands-on’ therapies.
Many herbal treatments, with hundreds of years of evidence through anecdotal and practitioner observation, have been discarded or made illegal for having ‘insufficient’ evidence, often because there has not been the finance available to put them through a typical modern day drug trial.
Power of placebo
That said, I believe that placebo has its place in healing. Remember, most drugs are tested against placebo and it nearly always has some benefit and sometimes more so than the drug being tested. There is a huge body of evidence supporting placebo. Perhaps placebo works better when a doctor has time to show deep interest and concern. The relationship between practitioner and patient must focus on the whole person. This is not possible when a patient is advised to bring only one symptom to a 10-minute consultation and all too frequently to be seen by different doctors. Arguably, if CAM were only to be working through placebo, it should automatically be considered a main stay of conventional therapy.
IM does not reject conventional prescribing and should not be confused with CAM that might be antagonistic. We must also not automatically accept alternative therapy uncritically, but remove the pre-fixes such as orthodox, complementary, functional, etc, and simply focuses on offering the ‘Medicine’.
Medical training, without doubt, allows practitioners to scrutinise evidence. Most GPs, spending up to 40% of their time on administration, rarely have time to study and consider therapies outside of major general practice journals which rarely have an integrated commentary. Whilst this situation exists we will continue to have doctors without interest or knowledge in alternatives and we will continue to have complementary medical practitioners without the safety net of medical training.
The Integrated Doctor is at least overcoming that obstacle.
Dr Rajendra Sharma is the author of the award winning “Live Longer, Live Younger” Watkins Publishers. He practices Integrated Medicine in Wimpole Street, London and in Exeter, Devon.
References
www.medicine.news/… Is complementary and alternative medicine (CAM) cost-effective? a systematic review
Lind BK, Lafferty WE, Tyree PT, Diehr PK. Comparison of health care expenditures among insured users and nonusers of complementary and alternative medicine in Washington State: a cost minimization analysis.J Altern Complement Med. 2010;16(4):411-417
Patricia M Herman, Benjamin M Craig, Opher Caspi BMC Complement Altern Med. 2005; 5: 11. Published online 2005 Jun 2. doi: 10.1186/1472-6882-5-11
Herman PM, Poindexter BL, Witt CM, et al. Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations BMJ Open 2012;2:e001046. doi: 10.1136/bmjopen-2012-001046
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.